Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

Author:

Munir Talha1ORCID,Brown Jennifer R.2,O'Brien Susan3ORCID,Barrientos Jacqueline C.4,Barr Paul M.5,Reddy Nishitha M.6,Coutre Steven7,Tam Constantine S.8,Mulligan Stephen P.9,Jaeger Ulrich10,Kipps Thomas J.11,Moreno Carol12ORCID,Montillo Marco13,Burger Jan A.14,Byrd John C.15,Hillmen Peter16,Dai Sandra17,Szoke Anita17,Dean James P.17,Woyach Jennifer A.15

Affiliation:

1. Department of Haematology St. James's University Hospital Leeds UK

2. CLL Center, Dana‐Farber Cancer Institute Boston Massachusetts

3. UC Irvine, Chao Family Comprehensive Cancer Center Irvine California

4. Division of Medical Oncology and Hematology Northwell Health Cancer Institute Lake Success New York

5. Wilmot Cancer Institute University of Rochester Medical Center Rochester New York

6. Vanderbilt‐Ingram Cancer Center Nashville Tennessee

7. Stanford Cancer Center Stanford University School of Medicine Stanford California

8. Peter MacCallum Cancer Centre St. Vincent's Hospital and University of Melbourne Melbourne Australia

9. Royal North Shore Hospital Sydney Australia

10. Division of Hematology and Hemostaseology Medical University of Vienna Wien Austria

11. UCSD Moores Cancer Center San Diego California

12. Hospital de la Santa Creu i Sant Pau Autonomous University of Barcelona Barcelona Spain

13. Niguarda Ca' Granda Hospital Milan Italy

14. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas

15. The Ohio State University Comprehensive Cancer Center Columbus Ohio

16. The Leeds Teaching Hospitals St. James Institute of Oncology Leeds UK

17. Pharmacyclics LLC, an AbbVie Company Sunnyvale California

Funder

Janssen Pharmaceuticals

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3